Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/33847
Type
ArticleCopyright
Open access
Collections
- INI - Artigos de Periódicos [3397]
Metadata
Show full item record
FACTORS ASSOCIATED WITH WILLINGNESS TO USE PRE-EXPOSURE PROPHYLAXIS IN BRAZIL, MEXICO, AND PERU: WEB-BASED SURVEY AMONG MEN WHO HAVE SEX WITH MEN
Men who have sex with men
Pre-exposure prophylaxis
Prevention
Surveys and questionnaires
Author
Affilliation
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Centro de Investigación Interdisciplinaria en Sexualidad Sida y Sociedad, UPCH, Lima, Peru.
Condesa & Condesa-Iztapalapa Specialized Clinics, Mexico City, Mexico./ National Institute of Psychiatry Ramon de la Fuente Muñiz, Mexico City, Mexico.
Centro de Investigación Interdisciplinaria en Sexualidad Sida y Sociedad, UPCH, Lima, Peru.
Condesa & Condesa-Iztapalapa Specialized Clinics, Mexico City, Mexico./ National Institute of Psychiatry Ramon de la Fuente Muñiz, Mexico City, Mexico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Center for Prevention and Comprehensive Healthcare for HIV/AIDS of Mexico City, Mexico City, Mexico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
National Institute of Public Health, Mexico City, Mexico.
National Institute of Psychiatry Ramon de la Fuente Muñiz, Mexico City, Mexico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Centro de Investigación Interdisciplinaria en Sexualidad Sida y Sociedad, UPCH, Lima, Peru.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI/Fiocruz), Rio de Janeiro, Brazil./ Centro de Investigación Interdisciplinaria en Sexualidad Sida y Sociedad, UPCH, Lima, Peru./ Condesa & Condesa-Iztapalapa Specialized Clinics, Mexico City, Mexico.
Centro de Investigación Interdisciplinaria en Sexualidad Sida y Sociedad, UPCH, Lima, Peru.
Condesa & Condesa-Iztapalapa Specialized Clinics, Mexico City, Mexico./ National Institute of Psychiatry Ramon de la Fuente Muñiz, Mexico City, Mexico.
Centro de Investigación Interdisciplinaria en Sexualidad Sida y Sociedad, UPCH, Lima, Peru.
Condesa & Condesa-Iztapalapa Specialized Clinics, Mexico City, Mexico./ National Institute of Psychiatry Ramon de la Fuente Muñiz, Mexico City, Mexico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Center for Prevention and Comprehensive Healthcare for HIV/AIDS of Mexico City, Mexico City, Mexico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
National Institute of Public Health, Mexico City, Mexico.
National Institute of Psychiatry Ramon de la Fuente Muñiz, Mexico City, Mexico.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Centro de Investigación Interdisciplinaria en Sexualidad Sida y Sociedad, UPCH, Lima, Peru.
Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em DST/AIDS. Rio de Janeiro, RJ, Brasil.
Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI/Fiocruz), Rio de Janeiro, Brazil./ Centro de Investigación Interdisciplinaria en Sexualidad Sida y Sociedad, UPCH, Lima, Peru./ Condesa & Condesa-Iztapalapa Specialized Clinics, Mexico City, Mexico.
Abstract
HIV disproportionally affects key populations including men who have sex with men (MSM). HIV prevalence among MSM varies from 17% in Brazil and Mexico to 13% in Peru, whereas it is below 0.5% for the general population in each country. Pre-exposure prophylaxis (PrEP) with emtricitabine/tenofovir is being implemented in the context of combination HIV prevention. Reports on willingness to use PrEP among MSM have started to emerge over the last few years. Previously reported factors associated with willingness to use PrEP include awareness, higher sexual risk behavior, and previous sexually transmitted infection.
Keywords
Latin AmericaMen who have sex with men
Pre-exposure prophylaxis
Prevention
Surveys and questionnaires
Share